LabGenius £35 million series B fundraise

Author:

Fiona Day

Published:

Sep 2024

Updated:

Aug 2026

Congratulations to LabGenius who recently announced a £35 million Series B fundraise.

We were approached by LabGenius to create a video demonstrating how they create drug candidates, how the drugs work at a molecular level and their benefits vs other formats. The goal was to help explain the unique ML-driven antibody discovery platform to investors.

[[video=791915983]]

[[related-case-study]]

Looking for something similar to help secure funding? Why not get in touch to find out how we can help you secure funding too.

OUR CLIENTS

Trusted by some of the world's leading pharmaceutical, biotech and medical communications teams - including AstraZeneca, Pfizer, Sanofi, Takeda, Lundbeck and Samsung Biologics.

“We were really happy with the work and our collaboration with you. You really have a good team - all your different skills enabled the different projects to swiftly move forward with high satisfaction on our side. Thanks again!”

International Project Manager, OM Pharma

“The video is very high quality and we are very impressed... we are really happy with the animation, great work!”

Global Brand Manager, Unilever

“Thanks, it all looks great! Thanks to everyone on the team for your hard work.”

Senior Publishing Manager, Springer Nature

“The video looks really great!!! We really love it. We shared the video internally and there were many great comments. Thank you so much.”

Specialist, CDO Business Team, Samsung Biologics

LabGenius £35 million series B fundraise

Congratulations to LabGenius who recently announced a £35 million Series B fundraise.

Do you have a burning question for us?